CENGILD Stock Overview
An investment holding company, operates a medical center in Malaysia. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Cengild Medical Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 0.28 |
| 52 Week High | RM 0.34 |
| 52 Week Low | RM 0.24 |
| Beta | -0.054 |
| 1 Month Change | -1.75% |
| 3 Month Change | 3.70% |
| 1 Year Change | -16.42% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -39.78% |
Recent News & Updates
Recent updates
Cengild Medical Berhad's (KLSE:CENGILD) Weak Earnings May Only Reveal A Part Of The Whole Picture
Jun 04
Cengild Medical Berhad (KLSE:CENGILD) Might Have The Makings Of A Multi-Bagger
Apr 05Investors Can Find Comfort In Cengild Medical Berhad's (KLSE:CENGILD) Earnings Quality
Sep 01A Look At The Fair Value Of Cengild Medical Berhad (KLSE:CENGILD)
Aug 31Shareholder Returns
| CENGILD | MY Healthcare | MY Market | |
|---|---|---|---|
| 7D | 3.7% | 1.9% | 1.9% |
| 1Y | -16.4% | 22.3% | 12.0% |
Return vs Industry: CENGILD underperformed the MY Healthcare industry which returned 22.3% over the past year.
Return vs Market: CENGILD underperformed the MY Market which returned 12% over the past year.
Price Volatility
| CENGILD volatility | |
|---|---|
| CENGILD Average Weekly Movement | 4.1% |
| Healthcare Industry Average Movement | 3.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in MY Market | 10.5% |
| 10% least volatile stocks in MY Market | 2.5% |
Stable Share Price: CENGILD has not had significant price volatility in the past 3 months compared to the MY market.
Volatility Over Time: CENGILD's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 159 | Wai Lee | cengild.com |
Cengild Medical Berhad, an investment holding company, operates a medical center in Malaysia. The company offers various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; general cardiology and gynecology assessment; gastroenterology and hepatology; anesthesiology, endocrinology, general surgery, internal medicine, orthopedic, plastic and reconstructive surgery, radiology, rheumatology, and thoracic surgery; ear, nose and throat; gastrointestinal surgeries, including upper gastrointestinal, hepatobiliary, pancreatic, colorectal surgery, and bariatric surgery; and chemotherapy. It also provides medical management services; nursing services and clinical support services; clinical laboratory and pharmacy; radiology and imaging services; dietetics and nutrition, physiotherapy, and medical record services; accident and emergency care, and health screenings; and consultant services.
Cengild Medical Berhad Fundamentals Summary
| CENGILD fundamental statistics | |
|---|---|
| Market cap | RM 237.38m |
| Earnings (TTM) | RM 11.48m |
| Revenue (TTM) | RM 71.54m |
20.3x
P/E Ratio3.3x
P/S RatioIs CENGILD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CENGILD income statement (TTM) | |
|---|---|
| Revenue | RM 71.54m |
| Cost of Revenue | RM 38.23m |
| Gross Profit | RM 33.31m |
| Other Expenses | RM 21.83m |
| Earnings | RM 11.48m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.014 |
| Gross Margin | 46.56% |
| Net Profit Margin | 16.05% |
| Debt/Equity Ratio | 0% |
How did CENGILD perform over the long term?
See historical performance and comparisonDividends
2.6%
Current Dividend Yield54%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 15:08 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cengild Medical Berhad is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hock Lon Chia | RHB Investment Bank |
| Kong Tan | TA Securities Holdings Berhad |